{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T09:33:50Z","timestamp":1773480830803,"version":"3.50.1"},"reference-count":7,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2018,8,17]]},"abstract":"<jats:p>Cystic fibrosis is the most common life-limiting genetic condition in Caucasians caused by Cystic Fibrosis Transmembrane conductance Regulator (CFTR) gene mutations. Sweat chloride is the current gold standard for diagnosis where values &gt;60\u2009mmol\/L are diagnostic and values &gt;30\u2009mmol\/L are indeterminate. There is limited literature on the effect of medications on the sweat chloride values. We report a case of topiramate being responsible for false-positive testing which resulted in overutilisation of medical resources and psychosocial stress on the family. Topiramate should be considered during the interpretation of the gold standard testing as one of the cause of false-positive sweat tests.<\/jats:p>","DOI":"10.1136\/bcr-2018-225697","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T13:36:00Z","timestamp":1536154560000},"page":"bcr-2018-225697","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of topiramate on sweat chloride level while screening for cystic fibrosis"],"prefix":"10.1136","volume":"2018","author":[{"given":"Roopa","family":"Siddaiah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eve","family":"Thau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin","family":"Graff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,9,5]]},"reference":[{"key":"2025042706103190000_2018.sep04_1.bcr-2018-225697.1","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2016.09.064","article-title":"Diagnosis of cystic fibrosis: Consensus guidelines from the cystic fibrosis foundation","volume":"181","author":"Farrell","year":"2017","journal-title":"J Pediatr"},{"key":"2025042706103190000_2018.sep04_1.bcr-2018-225697.2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21563"},{"key":"2025042706103190000_2018.sep04_1.bcr-2018-225697.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(85)80250-X"},{"key":"2025042706103190000_2018.sep04_1.bcr-2018-225697.4","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.lfs.2007.04.018","article-title":"Topiramate reduced sweat secretion and aquaporin-5 expression in sweat glands of mice","volume":"80","author":"Ma","year":"2007","journal-title":"Life Sci"},{"key":"2025042706103190000_2018.sep04_1.bcr-2018-225697.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2007.00062.x"},{"key":"2025042706103190000_2018.sep04_1.bcr-2018-225697.6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.pediatrneurol.2005.10.004","article-title":"Hypohidrosis during topiramate treatment: a rare and reversible side effect","volume":"34","author":"Cerminara","year":"2006","journal-title":"Pediatr Neurol"},{"key":"2025042706103190000_2018.sep04_1.bcr-2018-225697.7","doi-asserted-by":"crossref","unstructured":"Welsh MJ , Tsui L-C , Boat T , et al . Cystic fibrosis. In: The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill, 1995. p. 52.doi:10.1038\/scientificamerican1295-52","DOI":"10.1038\/scientificamerican1295-52"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-225697","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T13:10:40Z","timestamp":1745759440000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-225697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,5]]},"references-count":7,"alternative-id":["10.1136\/bcr-2018-225697"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-225697","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,5]]}}}